Huda Y. Zoghbi, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,638 shares at $774.68 ($1.3M) on 2026-02-19, disclosed to the SEC on 2026-02-23.
Open-market sale of $1.3M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $774.68 | 49 | $38K | 3.0% |
| 2 | $775.50 | 50 | $39K | 3.0% |
| 3 | $778.47 | 53 | $41K | 3.2% |
| 4 | $779.55 | 208 | $162K | 12.7% |
| 5 | $780.45 | 331 | $258K | 20.2% |
| 6 | $781.28 | 209 |
| $163K |
| 12.8% |
| 7 | $782.10 | 298 | $233K | 18.2% |
| 8 | $783.29 | 220 | $172K | 13.5% |
| 9 | $784.45 | 160 | $126K | 9.8% |
| 10 | $785.61 | 56 | $44K | 3.4% |
| 11 | $790.00 | 4 | $3K | 0.2% |
| Total | $781.33 avg | 1,638 | $1.3M | 100% |
| Filing → |
| REGN | SELL | 2023-10-17 | $850K | — | Filing → |
| REGN | SELL | 2022-03-18 | $1.4M | — | Filing → |
| REGN | SELL | 2021-09-15 | $650K | — | Filing → |